Within a year, the doctors at the Institut Gustave-Roussy hope to be able to offer their patients treated for breast cancer pills that simultaneously fight their disease while relieving them of the adverse effects of breast cancer. first treatment.
The hormonal therapies which are prescribed to them to prevent recurrence indeed induce painful side effects which often push them not to follow until their term the five years required of daily intake of the treatment.
Read also:
Breast cancer: an innovative drug that is long overdue
The Center for the fight against cancer located in Villejuif, in Val-de-Marne, launched a research program five years ago to assess the frequency of these treatment dropouts - what doctors call
"non-compliance"
.
"We realized that the phenomenon tends to be underestimated, because some women have difficulty declaring it when questioned"
, underlines Dr Barbara Pistilli, oncologist and head of the pathology committee.
This article is for subscribers only.
You have 67% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
